LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026

BURLINGTON, Mass., July 14, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2026 financial results on Tuesday, August 4, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook.

GlobeNewsWire • Jul 14, 2026

We Have A Valuation Problem - May Dividend Income Report

I don't love valuation models because they rely on assumptions, and assumptions can be dangerous. But we still need to pay attention. I sold my position in BIPC not because I don't like the stock or that I'm spooked by recent movement, but rather in the optic of portfolio simplification. Since I started this portfolio in September 2017, I have received a total of $36,444.54 CAD in dividends.

Seeking Alpha • Jun 18, 2026

Casey's & 3 More Stocks With Strong Interest Coverage to Buy Now

CASY, CLS, PNTG and LMAT stand out for strong interest coverage as borrowing costs rise, with solid sales/EPS growth estimates and big one-year gains.

Zacks Investment Research • May 26, 2026

LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why

LeMaitre (LMAT) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Investment Research • May 25, 2026

Portfolio Update - April Dividend Income Report

CGI reported a good quarter with revenue up 3.3% to $4.16B and diluted EPS up 10.6% to $2.09. Revenue growth was driven by acquisitions. ADP reported a strong quarter with revenue up 7% and adjusted EPS up 12%. Employer Services grew 7% to $3.3B on strong client retention and new business bookings. Since I started this portfolio in September 2017, I have received a total of $36,112.67 CAD in dividends.

Seeking Alpha • May 21, 2026

LeMaitre to Participate at Upcoming Investor Conferences in June

BURLINGTON, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in two upcoming investor conferences in June.

GlobeNewsWire • May 20, 2026

Down 17.2% in 4 Weeks, Here's Why LeMaitre (LMAT) Looks Ripe for a Turnaround

LeMaitre (LMAT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Zacks Investment Research • May 13, 2026

LeMaitre to Present at the Bank of America Healthcare Conference

BURLINGTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today that management will present at the Bank of America Healthcare Conference on Wednesday, May 13, 2026, at 5:15 PM PT.

GlobeNewsWire • May 7, 2026

3 Reasons Growth Investors Will Love LeMaitre (LMAT)

LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks Investment Research • May 7, 2026

LeMaitre (LMAT) Upgraded to Buy: Here's Why

LeMaitre (LMAT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research • May 7, 2026